3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
6
Lymphoma, Non-Hodgkin
6
Leukemia, Myeloid, Acute
5
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hodgkin Disease
3
Waldenstrom Macroglobulinemia
2
Sezary Syndrome
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma
2
Immunoblastic Lymphadenopathy
2
Hematologic Diseases
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Sarcoma, Synovial
1
Recurrence
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Interventions
Dexamethasone
4
pomalidomide
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
daratumumab
2
auricularum
2
Calcium Dobesilate
2
Bortezomib
2
navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid
1
ixazomib
1
carfilzomib
1
Specimen Handling
1
Peripheral Blood Stem Cell Transplantation
1
Panobinostat
1
Melphalan
1
Lenalidomide
1
Gemcitabine
1
Busulfan
1
Biopsy
1
2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Plasmacytoma
×
Leukapheresis
×
Clear all
No trials found.